The human brain: localized H-1 MR spectroscopy at 1.0 T

Area of Science:

• Neuroimaging
• Biomedical Engineering
• Medical Physics

Background:

• Localized proton magnetic resonance (MR) spectroscopy enables in vivo analysis of human brain metabolites.
• Previous studies utilized higher field strengths (1.5 and 2.0 T) for brain MR spectroscopy.
• Understanding brain tumor metabolism non-invasively is crucial for diagnosis and management.

Purpose of the Study:

• To evaluate the feasibility of localized H-1 MR spectroscopy at a lower field strength of 1.0 T for in vivo human brain investigations.
• To assess the capability of 1.0 T H-1 MR spectroscopy in detecting metabolic changes associated with brain tumors (astrocytomas).

Main Methods:

• Proton (H-1) MR spectroscopy was performed using the stimulated echo acquisition mode at 1.0 T.
• Studies included healthy volunteers (frontoparietal area, occipital lobe, cerebellum, pons) and two patients with astrocytomas.
• Fast low angle shot MR imaging was used to define regions of interest prior to spectral acquisition.

Main Results:

• H-1 MR spectra from astrocytomas showed characteristic alterations compared to normal brain tissue.
• Observed changes included reduced N-acetyl-aspartate and creatine resonances, increased choline signals, and a prominent lactate peak.
• The study demonstrated feasibility at 1.0 T with comparable spectral resolution and signal-to-noise ratio for key metabolites to higher field strengths.

Conclusions:

• Localized H-1 MR spectroscopy at 1.0 T is a viable technique for in vivo human brain studies.
• This lower field strength provides sufficient spectral quality to identify metabolic profiles of brain tumors.
• The findings support the use of 1.0 T MR spectroscopy as an accessible tool for neuro-oncology research and potentially clinical applications.